Phentolamine Ophthalmic Solution (Ocuphire Pharma)

N/A

Report date: 2025/06/09 20:00:12

Base Information

Drug NamePhentolamine Ophthalmic Solution (Ocuphire Pharma)
Drug Alias NamePhentolamine Ophthalmic Solution 0.75%0.75% Phentolamine Ophthalmic SolutionPhentolamine Ophthalmic Solution 1%Phentolamine Mesylate Ophthalmic SolutionNyxol +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsAdrenergic receptors alpha-2 antagonists
TargetsAdrenergic receptors alpha-1Adrenergic receptors alpha-2
Therapy Area/IndicationsNight BlindnessPresbyopiaMydriasis +[7] 
Global Approved IndicationsMydriasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2023/09/25
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOpus Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFamyGen Life Sciences IncViatris IncOpus Genetics Inc
Inactive CompaniesN/A
Active IndicationsNight BlindnessPresbyopiaMydriasis +[4] 
Inactive IndicationsGlaucoma, Open-AngleOcular HypertensionDeaf-Blind Disorders

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG